TCL Archive In Brief: MB Ends Apportionment Carlo Croce To Head Fels Institute, Replacing Peter Magee Sept. 1 March 4, 1988
TCL Archive Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says. May 7, 2004
